Developing Solid Oral Dosage Forms : Pharmaceutical Theory and Practice. için kapak resmi
Developing Solid Oral Dosage Forms : Pharmaceutical Theory and Practice.
Başlık:
Developing Solid Oral Dosage Forms : Pharmaceutical Theory and Practice.
Yazar:
Qiu, Yihong.
ISBN:
9780080932729
Yazar Ek Girişi:
Fiziksel Tanımlama:
1 online resource (976 pages)
İçerik:
Brief Table of Contents -- Table of Contents -- Copyright Page -- Dedication -- Foreword -- List of Contributors -- Part I. Theories And Techniques In The Characterization Of Drug Substances And Excipients -- Chapter 1. Solubility of Pharmaceutical Solids -- 1.1. Introduction -- 1.1.1. Implication of Solubility in Dosage Form Development -- 1.1.2. Basic Concepts of Solubilityand Dissolution -- 1.2. Thermodynamics of solutions -- 1.2.1. Volume of Mixing -- 1.2.2. Enthalpy of Mixing -- 1.2.3. Entropy of Mixing -- 1.2.4. Free Energy of Mixing -- 1.3. Theoretical estimation of solubility -- 1.3.1. Ideal Solutions -- 1.3.2. Effect of Crystallinity -- 1.3.3. Non-ideal Solutions -- 1.3.4. Regular Solution Theory -- 1.3.5. Aqueous Solution Theory -- 1.3.6. The General Solubility Equation (GSE) -- 1.4. Solubilization of drug candidates -- 1.4.1. Solubility Enhancement by pH Control and Salt Formation -- 1.4.2. Solubilization Using Complexation -- 1.4.3. Solubilization by Cosolvents -- 1.4.4. Solubilization by Surfactants (Micellar Solubilization) -- 1.4.5. Solubilization by Combinationof Approaches -- 1.5. Experimental determination of solubility -- 1.5.1. Stability of Solute and Solvent -- 1.5.2. Shakers and Containers -- 1.5.3. Presence of Excess Undissolved Solute -- 1.5.4. Determination of Equilibrium -- 1.5.5. Phase-separation -- 1.5.6. Determination of Solute Content in the Dissolved Phase -- 1.5.7. Experimental Conditions -- Uncited References -- Chapter 2. Crystalline and Amorphous Solids -- 2.1. Introduction -- 2.2. Definitions and Categorization of Solids -- 2.3. Thermodynamics and Phase Diagrams -- 2.3.1. Polymorphs -- 2.3.2. Solvates/Hydrates -- 2.3.3. Cocrystals -- 2.3.4. Amorphous Solids -- 2.4. Pharmaceutical Relevance and Implications -- 2.4.1. Solubility -- 2.4.2. Dissolution Rate and Bioavailability -- 2.4.3. Hygroscopicity.

2.4.4. Reactivity and Chemical Stability -- 2.4.5. Mechanical Properties -- 2.5. Transformations among Solids -- 2.5.1. Induced by Heat -- 2.5.2. Induced by Vapor -- 2.5.3. Induced by Solvents -- 2.5.4. Induced by Mechanical Stresses -- 2.6. Methods of Generating Solids -- 2.6.1. Through Gas -- 2.6.2. Through Liquid -- 2.6.3. Through Solid -- 2.7. Amorphous Drugs and Solid Dispersions -- 2.7.1. Characteristics of Amorphous Phases -- 2.7.2. Characteristics of Amorphous Solid Dispersions -- 2.7.3. Crystallization of Amorphous Drugs and Dispersions -- 2.8. Special Topics -- 2.8.1. Polymorph Screening and Stable Form Screening -- 2.8.2. High Throughput Crystallization -- 2.8.3. Miniaturization in Crystallization -- Uncited Reference -- Chapter 3. Analytical Techniques in Solid-state Characterization -- 3.1. Introduction -- 3.2. Review of Analytical Techniques and Methods -- 3.3. Microscopic Methods -- 3.3.1. Optical Microscopy -- 3.3.2. Electron Microscopy -- 3.4. Thermal Analysis -- 3.4.1. Differential Scanning Calorimetry -- 3.4.2. Thermogravimetric Analysis -- 3.4.3. Microcalorimetry -- 3.5. Diffraction Methods -- 3.5.1. Single-crystal X-ray Diffraction -- 3.5.2. Powder X-ray Diffraction -- 3.6. Vibrational Spectroscopy -- 3.6.1. Infrared Spectroscopy -- 3.6.2. Raman Spectroscopy -- 3.6.3. Near-infrared -- 3.7. Solid-state Nuclear Magnetic Resonance Spectroscopy -- 3.8. Sorption Techniques -- 3.9. Other Techniques -- 3.10. Characterization of Solids Using Complementary Analytical Techniques -- 3.11. Conclusion -- Acknowledgements -- Chapter 4. Salt Screening and Selection -- 4.1. Introduction -- 4.2. Theoretical Considerations -- 4.2.1. pH-Solubility Profiles and the Role of pKa -- 4.2.2. Prediction of Salt Solubility and In Situ Salt Screening -- 4.2.3. Solubility and Dissolution Rate of Salts -- 4.2.4. Dissolution of Salts in GI Fluids.

4.2.5. Impact of Salt Form on Other Solubilization Techniques -- 4.2.6. Effect of Salts on Chemical Stability -- 4.2.7. Potential Disadvantages of Salts -- 4.3. Practical Considerations -- 4.3.1. Drug Substance Considerations -- 4.3.2. Dosage Form Considerations -- 4.3.3. Toxicity Considerations -- 4.3.4. Salt and Form Screening and Selection Strategies -- 4.3.5. The Role of Automation and High Throughput Designs in Salt Screening -- 4.4. Conclusions -- Uncited Reference -- Chapter 5. Drug Stability and Degradation Studies -- 5.1. Introduction -- 5.2. Chemical stability -- 5.2.1. Solution Kinetics -- 5.2.2. Rate Equations -- 5.2.3. Elemental Reactions and Reaction Mechanism -- 5.2.4. Typical Simple Order Kinetics -- 5.2.5. Complex Reactions -- 5.2.6. Arrhenius Equation, Collision Theory, and Transition State Theory -- 5.2.7. Catalysts and Catalysis -- 5.2.8. pH-rate Profiles -- 5.2.9. Solid-state Reaction Kinetics -- 5.2.10. Solid-state Kinetic Models -- 5.2.11. Physical Parameters Affecting Solid-state Kinetics -- 5.2.12. The Role of Moisture -- 5.2.13. Topochemical Reactions -- 5.3. Common pathways of drug degradation -- 5.3.1. Hydrolysis -- 5.3.2. Oxidative Degradation -- 5.3.3. Photochemical Degradation -- 5.3.4. Other Degradation Pathways -- 5.4. Experimental approaches to studying the chemical degradation of drugs -- 5.4.1. Solution Thermal Degradation Studies -- 5.4.2. Solid-state Thermal Degradation Studies -- 5.4.3. Oxidative Degradation Studies -- 5.4.4. Photodegradation Studies -- 5.5. Physical stability and phase transformations[106] -- 5.5.1. Types of Phase Transformations -- 5.5.2. Mechanisms of Phase Transformations -- 5.6. Phase transformations during pharmaceutical processing106 -- 5.6.1. Processes for Preparing Solid Dosage Forms and Associated Potential Phase Transformations.

5.6.2. Anticipating and Preventing Phase Transformations in Process Development -- Chapter 6. Excipient Compatibility -- 6.1. Introduction -- 6.2. Chemistry of Drug-Excipient Interactions -- 6.2.1. Influence of Water and Microenvironmental pH -- 6.2.2. Reactions with Excipients and their Impurities -- 6.2.3. Stabilizing Excipients -- 6.3. Current Practices -- 6.3.1. Experimental Design -- 6.3.2. Sample Preparation and Storage -- 6.3.3. Sample Analysis and Data Interpretation -- 6.4. Conclusions -- Chapter 7. Theory of Diffusion and Pharmaceutical Applications -- 7.1. Introduction -- 7.1.1. Basic Equations of Diffusion -- 7.1.2. Solutions for Diffusion Equations -- 7.2. The diffusion coefficient and its determination -- 7.2.1. Steady State Flux Method -- 7.2.2. Lag Time Method -- 7.2.3. Sorption and Desorption Methods -- 7.3. Pharmaceutical applications -- 7.3.1. Controlled Release -- 7.3.2. Particle Dissolution -- 7.3.3. Packaging Study -- 7.4. Appendix -- 7.4.1. The Error Function and Its Application -- 7.4.2. Derivation of Solution by Separation of Variables -- Chapter 8. Particle, Powder, and Compact Characterization -- 8.1. Introduction -- 8.2. Particle sizecharacterization -- 8.2.1. Light Microscopy -- 8.2.2. Scanning Electron Microscopy -- 8.2.3. Sieving -- 8.2.4. Light Diffraction -- 8.2.5. Importance/Impact of Particle Size Characterization -- 8.3. Powder characterization -- 8.3.1. Density -- 8.3.2. Flow -- 8.4. Compact (mechanical property) characterization -- 8.4.1. Important Mechanical Properties -- 8.4.2. Overview of Methods -- 8.4.3. Quasi-static Testing -- 8.4.4. Dynamic Testing -- 8.5. Conclusions -- Chapter 9. Polymer Properties and Characterization -- 9.1. Introduction -- 9.1.1. Definition, Structure, and Nomenclature -- 9.1.2. Types of Homopolymers and Copolymers -- 9.2. Commonly used cellulose derivatives in solid oral products.

9.3. Basic concepts and characterization of polymeric materials -- 9.3.1. Polymer Composition -- 9.3.2. Molecular Weight -- 9.3.3. Polymers in Solution -- 9.3.4. Structure-Property Relationships -- 9.4. Conclusion -- Uncited References -- Chapter 10. Applied Statistics in Product Development -- 10.1. Introduction -- 10.1.1. Statistics: A Tool for Decision Making and Risk Assessment -- 10.1.2. Sources of Uncertainty -- 10.1.3. Natural (Random) Variation -- 10.1.4. Systematic Error (Bias) and Blunders -- 10.2. Exploring data: types of data -- 10.2.1. Nominal (Categorical) Data -- 10.2.2. Ordinal Data -- 10.2.3. Numerical Data -- 10.2.4. Continuously Variable Data and Digitization Pitfalls -- 10.3. Exploring data: graphical techniques -- 10.3.1. Graphing Nominal Data -- 10.3.2. Bar Charts -- 10.3.3. Pie Charts -- 10.3.4. Graphing Univariate Numerical Data -- 10.3.5. Histograms -- 10.3.6. Quantile Plots -- 10.3.7. Box Plots -- 10.3.8. Graphing Bivariate Data -- 10.3.9. One Variable Nominal: Bar Graphs, Dot Plots, and Line Plots -- 10.3.10. One Variable Nominal: Box Plots -- 10.3.11. Both Variables Numeric and Random: Quantile-Quantile Plots -- 10.3.12. Both Variables Numeric: Scatterplots -- 10.3.13. Multivariate Data -- 10.3.14. Scatterplot Matrices -- 10.4. Data distributions -- 10.4.1. Binomial Distribution -- 10.4.2. Poisson Distribution -- 10.4.3. Normal (Gaussian) Distribution -- 10.4.4. Other Useful Distributions -- 10.5. Location: central tendencies -- 10.5.1. Data for Central Value and Dispersion Examples -- 10.5.2. Arithmetic Mean -- 10.5.3. Median -- 10.6. Dispersion -- 10.6.1. Range -- 10.6.2. Interquartile Range and Median Absolute Deviation from the Median -- 10.6.3. Variance and Standard Deviation -- 10.6.4. Coefficient of Variation -- 10.6.5. Multivariate Covariance and Correlation -- 10.6.6. Correlation and Causality.

10.6.7. Error Propagation.
Özet:
This book is intended for pharmaceutical professionals engaged in research and development of oral dosage forms. It covers essential principles of physical pharmacy, biopharmaceutics and industrial pharmacy as well as various aspects of state-of-the-art techniques and approaches in pharmaceutical sciences and technologies along with examples and/or case studies in product development. The objective of this book is to offer updated (or current) knowledge and skills required for rational oral product design and development. The specific goals are to provide readers with: Basics of modern theories of physical pharmacy, biopharmaceutics and industrial pharmacy and their applications throughout the entire process of research and development of oral dosage forms Tools and approaches of preformulation investigation, formulation/process design, characterization and scale-up in pharmaceutical sciences and technologies New developments, challenges, trends, opportunities, intellectual property issues and regulations in solid product development The first book (ever) that provides comprehensive and in-depth coverage of what's required for developing high quality pharmaceutical products to meet international standards It covers a broad scope of topics that encompass the entire spectrum of solid dosage form development for the global market, including the most updated science and technologies, practice, applications, regulation, intellectual property protection and new development trends with case studies in every chapter A strong team of more than 50 well-established authors/co-authors of diverse background, knowledge, skills and experience from industry, academia and regulatory agencies.
Notlar:
Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2017. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
Elektronik Erişim:
Click to View
Ayırtma: Copies: